《港樓》太古地產(01972.HK)柴灣海德園日內公布樓書 提供850伙
太古地產(01972.HK)與中華汽車(00026.HK)合作發展的柴灣前中巴車廠重建項目「海德園」日內公布售樓書,項目提供850伙,分兩期發展,提供一房至四房戶型。
海德園由三座住宅大樓組成,合共提供850伙,實用面積約400至1,400平方呎,一房實用面積約400平方呎、佔72伙;兩房實用面積約由500至600平方呎、佔479伙;三房實用面積約由750至1,100平方呎、佔259伙;四房實用面積約為1,400平方呎、佔38伙。至於海德園的兩伙特色戶,實用面積1,700至2,900平方呎。海德園第一期及第二期預計關鍵日期為2026年8月31日及2027年2月28日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.